Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

7
results for

"Endothelial cell"

Article category

Keywords

Publication year

"Endothelial cell"

Review

Liver fibrosis, cirrhosis, and portal hypertension

Sinusoidal communication in chronic liver disease
Albert Gibert-Ramos, María Andrés-Rozas, Raül Pastó, Pablo Alfaro-Retamero, Sergi Guixé-Muntet, Jordi Gracia-Sancho
Clin Mol Hepatol 2025;31(1):32-55.
Published online October 2, 2024
DOI: https://doi.org/10.3350/cmh.2024.0734
The liver sinusoid, mainly composed of liver sinusoidal endothelial cells, hepatic macrophages and hepatic stellate cells, shapes the hepatic vasculature and is key to maintaining liver homeostasis and function. During chronic liver disease (CLD), the function of sinusoidal cells is impaired, being directly involved in the progression of liver fibrosis, cirrhosis, and main clinical complications including portal hypertension and hepatocellular carcinoma. In addition to their roles in liver diseases pathobiology, sinusoidal cells’ paracrine communication or cross-talk is being studied as a mechanism of disease but also as a remarkable target for treatment. The aim of this review is to gather current knowledge of intercellular signalling in the hepatic sinusoid during the progression of liver disease. We summarise studies developed in pre-clinical models of CLD, especially emphasizing those pathways characterized in human-based clinically relevant models. Finally, we describe pharmacological treatments targeting sinusoidal communication as promising options to treat CLD and its clinical complications.

Citations

Citations to this article as recorded by  Crossref logo
  • Hepatic Fibrosis and Liver Cancer
    Aina Anton, Scott L. Friedman, Bruno Cogliati
    Seminars in Liver Disease.2026; 46(01): 031.     CrossRef
  • Regression of fibrosis and portal hypertension in chronic liver disease: Endothelial perspectives and clinical implications
    Yuly P Mendoza, Raül Pastó, Sonia E Selicean, Jordi Gracia-Sancho
    Annals of Hepatology.2026; 31(1): 102174.     CrossRef
  • LSEC-derived CXCL9 orchestrates immune recruitment and hepatocyte reprogramming in liver fibrosis
    Jing Li, Qiannan Di, Xiujuan Zhou, Mengling Chang, Wei Chen
    Acta Biochimica et Biophysica Sinica.2026;[Epub]     CrossRef
  • Nodular Transformation–driven Circulatory Remodeling in Biliary Atresia–induced Pediatric Biliary Cirrhosis: A Three-dimensional Phase-Contrast CT Rendering
    Bei-Ning Qi, Xin-Yan Zhao, Wen-Juan Lv, Shan Shan, Xian-qin Du, Jian-Bo Jian, Chun-Hong Hu
    Radiology.2026;[Epub]     CrossRef
  • Sinusoidal cell–derived biomarker scores predict diagnosis and prognosis in chronic liver disease
    Sergi Guixé-Muntet, Anabel Fernández-Iglesias, David Lopez, Emilio Tonina, Yiliam Fundora, Anna Zagorska, Jordi Gracia-Sancho
    BMC Medicine.2026;[Epub]     CrossRef
  • P7C3 alleviates hepatic fibrosis via targeting eIF4A1-mediated protein translation and autophagy in hepatic stellate cells
    Ailing Liang, Ling Yao, Yuanyuan Liu, Honglin He, Yao Lei, Yunheng Yang, Jun Liu, Jiamei Yu, Weiguo Cao, Zhiwei Chen
    Archives of Pharmacal Research.2026; 49(2): 262.     CrossRef
  • Clinical challenges and transjugular intrahepatic portosystemic shunt strategies for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: an Asian perspective
    Tan-Yang Zhou, Hong-Liang Wang, Zhi-Cheng Jin, Bin Xiong, Ji Hoon Shin
    Korean Journal of Interventional Radiology.2026; 31(1): 24.     CrossRef
  • Kupffer cells and monocyte-derived macrophages in the pathogenesis and treatment of hepatocellular carcinoma
    Argyro Voumvouraki, Ioannis Tsomidis, Elias Kouroumalis
    Hepatoma Research.2026;[Epub]     CrossRef
  • Extracellular Vesicles in Hepatic Pathogenesis: From Biogenesis to Biomarkers
    Tamer A. Addissouky
    Archives of Molecular Biology and Genetics.2026; 5(1): 10.     CrossRef
  • Vasomics of the liver
    Chengyan Wang, Eric Felli, Jonathan Andrew Fallowfield, Christoph Frank Dietrich, Don Rockey, Jürgen Hennig, Gao-Jun Teng, Jordi Gracia-Sancho, Xiaolong Qi
    Gut.2025; 74(6): 1008.     CrossRef
  • Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells
    Enis Kostallari, Robert F. Schwabe, Adrien Guillot
    Cellular & Molecular Immunology.2025; 22(10): 1205.     CrossRef
  • Myeloid cells in chronic liver inflammation
    Dimitrios Patseas, Ahmed El-Masry, Zuobin Liu, Prakash Ramachandran, Evangelos Triantafyllou
    Cellular & Molecular Immunology.2025; 22(10): 1237.     CrossRef
  • Toll-like receptor 4-mediated inflammatory stimulation in Kupffer cell enhances arsenite-induced liver fibrosis by triggering hepatic stellate cell activation
    Qian Song, Meitong Zhou, Rui He, Heng Diao, Lili Fan, Chenglong Tu, Xiong Chen, Dapeng Wang
    Ecotoxicology and Environmental Safety.2025; 303: 118903.     CrossRef
  • The pathophysiological role of portal hypertension in metabolic dysfunction–associated steatotic liver disease
    Søren Møller, Sannia M.S. Sjöstedt, Lise Hobolth, Christian Mortensen, Nina Kimer
    Hepatology Communications.2025;[Epub]     CrossRef
  • Hepatocyte-derived extracellular vesicles promote endothelial dedifferentiation in chronic liver disease through the miR-153-3p-pyroptosis axis
    Laia Abad-Jordà, María Andrés-Rozas, Ana Martínez-Alcocer, Jessica Aspas, Yiliam Fundora, Sonia Fernández-Veledo, Carmen Peralta, Sergi Guixé-Muntet, Anabel Fernández-Iglesias, Jordi Gracia-Sancho
    Hepatology.2025;[Epub]     CrossRef
  • 12,429 View
  • 321 Download
  • 12 Web of Science
  • Crossref

Correspondences

Liver fibrosis, cirrhosis, and portal hypertension

Citations

Citations to this article as recorded by  Crossref logo
  • Liver Fibrosis: Molecular Pathogenesis and Therapeutic Interventions
    Jiaorong Qu, Wenqing Qin, Minghang Dong, Zhi Ma, Si Li, Runping Liu, Ranyun Chen, Changmeng Li, Xiaojiaoyang Li
    MedComm.2026;[Epub]     CrossRef
  • 6,572 View
  • 63 Download
  • 1 Web of Science
  • Crossref

Cholestatic liver disease

Both liver parenchymal and non-parenchymal cells express JCAD protein under various circumstances
Li Xie, Li Zhang, Hui Chen, Yong-Yu Yang, Jian Wu
Clin Mol Hepatol 2024;30(2):279-280.
Published online March 20, 2024
DOI: https://doi.org/10.3350/cmh.2024.0191

Citations

Citations to this article as recorded by  Crossref logo
  • Correspondence on Letter regarding “Both liver parenchymal and non-parenchymal cells express JCAD proteins under various circumstances”
    Byoung Kuk Jang
    Clinical and Molecular Hepatology.2024; 30(2): 297.     CrossRef
  • 7,133 View
  • 76 Download
  • 1 Web of Science
  • Crossref

Reviews

Liver fibrosis, cirrhosis, and portal hypertension

Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis
Jiaorong Qu, Le Wang, Yufei Li, Xiaojiaoyang Li
Clin Mol Hepatol 2024;30(3):303-325.
Published online February 28, 2024
DOI: https://doi.org/10.3350/cmh.2024.0022
Liver sinusoidal endothelial cells (LSECs) are liver-specific endothelial cells with the highest permeability than other mammalian endothelial cells, characterized by the presence of fenestrae on their surface, the absence of diaphragms and the lack of basement membrane. Located at the interface between blood and other liver cell types, LSECs mediate the exchange of substances between the blood and the Disse space, playing a crucial role in maintaining substance circulation and homeostasis of multicellular communication. As the initial responders to chronic liver injury, the abnormal LSEC activation not only changes their own physicochemical properties but also interrupts their communication with hepatic stellate cells and hepatocytes, which collectively aggravates the process of liver fibrosis. In this review, we have comprehensively updated the various pathways by which LSECs were involved in the initiation and aggravation of liver fibrosis, including but not limited to cellular phenotypic change, the induction of capillarization, decreased permeability and regulation of intercellular communications. Additionally, the intervention effects and latest regulatory mechanisms of anti-fibrotic drugs involved in each aspect have been summarized and discussed systematically. As we studied deeper into unraveling the intricate role of LSECs in the pathophysiology of liver fibrosis, we unveil a promising horizon that pave the way for enhanced patient outcomes.

Citations

Citations to this article as recorded by  Crossref logo
  • Dark tea ameliorates liver fibrosis via FXR/TGR5-mediated intestinal permeability and liver sinusoidal capillarization
    Chen-Yu Wang, Sen Liu, Chong Gao, Xu Dai, Li-Hua Lian, Zhen-Yu Cui, Ji-Xing Nan, Yan-Ling Wu
    Journal of Ethnopharmacology.2026; 354: 120537.     CrossRef
  • Targeting LOXL1-expressing Hepatic Stellate Cell Inhibits Fibrogenesis and Sinusoid Angiogenesis via LOXL1/RUNX1/VEGFA Axis During Progression of Liver Fibrosis
    Xuzhen Yan, Qi Han, Yiwen Wang, Weiyu Li, Ning Zhang, Xu Fan, Wei Chen, Hong You, Aiting Yang
    Cellular and Molecular Gastroenterology and Hepatology.2026; 20(2): 101637.     CrossRef
  • Spatial patterning strategies for liver tissue engineering: Biofabrication technologies and applications
    Haram Nah, Ashlin R. Michell, Kerry M. Rogy, Owen J. Lally, Salman R. Khetani
    Advanced Drug Delivery Reviews.2026; 228: 115737.     CrossRef
  • Precision Targeting of Hepatic Stellate Cells: Nanotherapeutic Strategies for Liver Fibrosis Regression
    Xinying Ma, Dawei Chen, Ming Zhao, Haiyang Hu
    WIREs Nanomedicine and Nanobiotechnology.2026;[Epub]     CrossRef
  • Hepatic Fibrosis and Liver Cancer
    Aina Anton, Scott L. Friedman, Bruno Cogliati
    Seminars in Liver Disease.2026; 46(01): 031.     CrossRef
  • Integrating single-cell RNA sequencing with spatial transcriptomics reveal the fibrosis-related genes in hepatocellular carcinoma
    Wenying Qiao, Lei Li, Ronghua Jin, Caixia Hu
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • OGT-enriched Hepatocyte-derived Extracellular Vesicles Promote Capillarization of Liver Sinusoidal Endothelial Cells in Metabolic Dysfunction-associated Steatotic Liver Disease
    Yanjin Wang, Xulin Zhou, Yu Zhang, Fuji Yang, Yifei Chen, Yanshuang Wu, Lin Zhang, Junfei Tan, Wei Luo, Jing Zhou, Yongmin Yan
    Cellular and Molecular Gastroenterology and Hepatology.2026; 20(5): 101721.     CrossRef
  • LSEC-derived CXCL9 orchestrates immune recruitment and hepatocyte reprogramming in liver fibrosis
    Jing Li, Qiannan Di, Xiujuan Zhou, Mengling Chang, Wei Chen
    Acta Biochimica et Biophysica Sinica.2026;[Epub]     CrossRef
  • Kupffer cells: Orchestrators of liver physiology
    Qin Cai, Yusi Chen, Li Tang
    Liver Research.2026;[Epub]     CrossRef
  • HBV reprograms the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic implications
    Xiaodong Shen, Hechen Huang, Jianpeng Sheng, Xiaofeng Tang
    Clinical and Experimental Medicine.2026;[Epub]     CrossRef
  • Extracellular Vesicles in Liver Fibrosis: Pathogenic Messengers, Diagnostic Biomarkers, and Therapeutic Nanovectors
    Xinyi Zhao, Junyan Zhu, Tianyi Zhang, Wenrong Xu, Hui Qian
    Pharmaceutics.2026; 18(2): 230.     CrossRef
  • Engineered exosomes from umbilical cord mesenchymal stem cells with pPB modification attenuate hepatic fibrosis via hepatic stellate cell targeting
    Fanghong Wang, Zongbin Sun, Qiuxia Zheng, Xiaofeng Wei, Lu Zhang, Xiaoliang Zhu, Kexiang Zhu, Xiaojing Song, Ping Yue, Fanghui Ding, Lei Zhang, Xun Li
    Journal of Translational Medicine.2026;[Epub]     CrossRef
  • Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies
    Xiangqi Chen, Jinhang Zhang, Ling Guo, Chuan Wu, Jingyue Zhou, Mingzhu Xu, Li Mo, Yanping Li, Jinhan He
    Signal Transduction and Targeted Therapy.2026;[Epub]     CrossRef
  • The Effect of Somatostatin on Mediators of Liver Inflammation and Fibrosis in Viral Cirrhosis
    Angeliki Tsakou, George Notas, Constantinos Xidakis, Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis
    Livers.2026; 6(2): 16.     CrossRef
  • Salvianolic acid C attenuates liver fibrosis and inhibites hepatic stellate cell activation by targeting FAP/TβRI/SMAD axis
    Tao Sun, Xue Zheng, Liang Li, Jin Chu, Qiang Guo, Ning Yang, Xue Zhang, Xiaotong Li, Bowen Shi, Hongbin Zhang, Guodong Lü, Lufeng Cheng, Renyong Lin, Xiaojuan Bi
    International Immunopharmacology.2026; 175: 116400.     CrossRef
  • From bench to bedside: Molecular mechanisms, diagnostic tools, and therapeutic strategies in liver fibrosis
    Zhen Yang, Weizhao Tong, Kanglong Zhang, Guoxin Hu
    Liver Research.2026;[Epub]     CrossRef
  • Immunotherapy in liver metastases: Challenges, emerging evidence, and future directions
    Hoang Tran Pham, Zhong-Yi Dong, Margarita De Alba, Chasen Cottle, Ming-Yi Zhang, Joseph B Parker, Renee Morecroft-Phillipps, Keyur Chaludiya, Demarcus Ingram, Ayesha N Ahmad, Zhen Zeng, Michael M Mohseni, Zi-Zhen Zhang, Libardo Rueda Prada, Muhammad Ali,
    World Journal of Clinical Oncology.2026;[Epub]     CrossRef
  • Endothelial Cell Therapy for the Acute and Chronic Liver Disease
    Dilnar Mahmut, Valerie Gouon-Evans
    Seminars in Liver Disease.2026; 46(01): 077.     CrossRef
  • The Role of MicroRNAs in the Progression of Metabolic Dysfunction-associated Steatotic Liver Disease
    Jang Hyun Choi
    Journal of Digestive Cancer Research.2026; 14(1): 82.     CrossRef
  • Recent advances in plant-derived exosome-like nanovesicles for the treatment of liver diseases: from natural extracts to precision nanomedicine
    Siyue Li, Haotian Zhang, Xinyao Zhang, Yaying Wang, Zhi Peng, Lu Yuan, Haoran Wang, Fanxing Xu, Fei Han
    Chemical Engineering Journal.2026; 539: 176899.     CrossRef
  • Liver Fibrosis: Molecular Pathogenesis and Therapeutic Interventions
    Jiaorong Qu, Wenqing Qin, Minghang Dong, Zhi Ma, Si Li, Runping Liu, Ranyun Chen, Changmeng Li, Xiaojiaoyang Li
    MedComm.2026;[Epub]     CrossRef
  • ROCK2 inhibitor targets vascular niche angiocrine signaling in liver fibrosis
    Pingxin Sun, Chunyan Wang, Wenlin Li
    Trends in Pharmacological Sciences.2026; 47(6): 587.     CrossRef
  • Piezo1/2 in Fibrosis: Cell-Type-Specific Roles, Organ-Specific Pathogenesis, and Therapeutic Implications
    Lin Chen, Guorui Li, Mingqiong Tong, Na Song, Yaru Jin, Dan Wang, Yanyan Zhao, Xueting Yang, Yaqing Ge, Sha Liu, Xiangling Gu
    Burns.2026; : 108078.     CrossRef
  • P38γ drives aerobic glycolysis in liver sinusoidal endothelial cells and regulates alcoholic liver disease via the PFKFB3 signaling pathway
    Qian Zhang, Miao Yang, Yun Zhang, Jing Hu
    Molecular Biology Reports.2026;[Epub]     CrossRef
  • Sinusoidal endothelial cells control liver inflammation and fibrosis
    Yingfen Chen, Yong He
    Journal of Clinical Investigation.2026;[Epub]     CrossRef
  • Recent advances of nanomaterials in imaging liver fibrosis
    Jin Cui, Shuxuan Zhang, Xueli Xu, Ke Ren, Mengzhen Dong, Zhaokun Nie, Yang Xu, Xiaohui Dai, Peng Xu, Shuo Sun, Xinya Zhao, Xiao Sun
    BMEMat.2025;[Epub]     CrossRef
  • Immune Checkpoints and the Immunology of Liver Fibrosis
    Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis
    Livers.2025; 5(1): 5.     CrossRef
  • Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension
    Yanqiu Li, Bingbing Zhu, Ke Shi, Yu Lu, Xuanwei Zeng, Yongqi Li, Qun Zhang, Ying Feng, Xianbo Wang
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
    Xiao Ma, Tengda Huang, Xiangzheng Chen, Qian Li, Mingheng Liao, Li Fu, Jiwei Huang, Kefei Yuan, Zhen Wang, Yong Zeng
    Signal Transduction and Targeted Therapy.2025;[Epub]     CrossRef
  • Injury and Fibrosis at the Myoaponeurotic Junction of Pectoralis Major and Supracoracoideus Muscles in Broiler Chickens
    Takeshi Kawasaki, Tomohito Iwasaki, Takafumi Watanabe, Michi Yamada, Naoyuki Maeda, Yasuhiro Hasegawa, Naoki Takahashi, Ryosuke Kobayashi
    The Journal of Poultry Science.2025; 62: n/a.     CrossRef
  • Sulfur dioxide-releasing nanomotors improve the therapeutic effect of liver fibrosis by restoring the fenestrae of sinusoids
    Lin Chen, Zhengwei Chen, Di Shi, Haifeng Ke, Chun Mao, Mimi Wan
    Journal of Colloid and Interface Science.2025; 692: 137557.     CrossRef
  • Reconstructing the hepatocellular carcinoma microenvironment: the current status and challenges of 3D culture technology
    Ting Xiong, Kai Wang
    Discover Oncology.2025;[Epub]     CrossRef
  • Liver Sinusoidal Endothelial Cells in the Regulation of Immune Responses and Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
    Munish Puri, Snehal Sonawane
    International Journal of Molecular Sciences.2025; 26(9): 3988.     CrossRef
  • Chronic Inflammation and Immune Dysregulation in Metabolic-Dysfunction-Associated Steatotic Liver Disease Progression: From Steatosis to Hepatocellular Carcinoma
    Young-Min Jee, Jeong-Yoon Lee, Tom Ryu
    Biomedicines.2025; 13(5): 1260.     CrossRef
  • Mechanism-guided drug development and treatment for liver fibrosis: a clinical perspective
    Xiangchang Zeng, Deliang Huang, Zhibin Zhu, Qingxian Cai, Yang Yang, Hongzhou Lu, Jun Chen
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Targeting endoplasmic reticulum proteostasis in liver fibrosis: From signaling mechanisms to therapeutic opportunities
    Yawei Kong, Zhengyang Chen, Zhentian Nie, Wei Chen
    Pharmacological Research.2025; 217: 107823.     CrossRef
  • Reactive oxygen species-responsive micelles targeting activated hepatic stellate cells for treating liver fibrosis
    Xin Yu Liu, He Ying Mao, Jun Sheng Hu, Tong Rui Dou, Ben Chi Liu, Chang Xiu Lin, Cheng-Hua Jin, Ming Guan Piao
    Journal of Controlled Release.2025; 385: 113997.     CrossRef
  • Liver Sinusoidal Endothelial Cells and Their Regulation of Immunology, Collagenization, and Bioreactivity in Fatty Liver: A Narrative Review
    Reem J. Abdulmajeed, Consolato M. Sergi
    International Journal of Molecular Sciences.2025; 26(16): 8006.     CrossRef
  • From cooperation to collapse: systemic failure in liver disease through a sociological lens
    Junyu Wang, Jingting Lei, Martin C. Harmsen, Han Moshage
    Exploration of Digestive Diseases.2025;[Epub]     CrossRef
  • Anogeissus leiocarpus (DC.) Guill. & Perr. extract-protected rats against CCl4-induced liver fibrosis
    Omokolade O. Alejolowo, Olarewaju M. Oluba, Oluyomi S. Adeyemi
    Journal of Taibah University Medical Sciences.2025; 20(4): 474.     CrossRef
  • Anti-hepatic fibrosis activity and mechanisms of natural polysaccharides: A comprehensive review
    Xing Yang, Mingyi Shao, Ruixia Zhao, Rui Li, Bingzhao Du, Qian Bi, Yanan Liu, Hongyan Cui
    International Journal of Biological Macromolecules.2025; 328: 147678.     CrossRef
  • 4EBP1 phosphorylation mediates TGF-β1-induced hepatic fibrosis and upregulates HIF-1α expression
    Yue Shi, Zhandong Lin, Congyue Zhang, Jiawei Cui, Yaoyao Mao, Mengjiao Sun, Dandan Zhao, Yuemin Nan, Dianxing Sun
    iScience.2025; 28(9): 113412.     CrossRef
  • YAP contributes to liver injury through mediating capillarization of liver sinusoidal endothelial cells via GATA6/eNOS signaling
    Junjun Wang, Zhenyang Shen, Guangwen Chen, Weiming Dai, Zhu Mei, Bo Shen, Yuecheng Guo, Jianxiang Wang, Hanjing Zhangdi, Qingqing Zhang, Jiaqi Gao, Qichao Ge, Hui Zhou, Hui Dong, Lungen Lu, Xiaobo Cai
    Cellular & Molecular Biology Letters.2025;[Epub]     CrossRef
  • Genomic medicine in hepatology: mechanisms and liver treatment strategies
    D. S. Kozlov, S. Rodimova, P. Filatov, A. Mozherov, P. S. Timashev, M. V. Zyuzin, D. S. Kuznetsova
    Molecular Medicine.2025;[Epub]     CrossRef
  • Piezo-mediated mechanically activated currents in organ fibrosis: Novel mechanisms and therapeutic strategies
    Ling Dong, Li-Chan Lin, Sui Mao, Zhen-Yu Liu, Peng Liu, Rui Li, Hui Tao, Ye Zhang
    Life Sciences.2025; 382: 124050.     CrossRef
  • Retinal Sensitivity Loss and Beyond in KCNV2-Related Retinopathy: The First Genetically Confirmed Case in Türkiye
    Özlem Ural Fatihoğlu, Ayşe Bozkurt Oflaz, Özlem Özkan, Hande Taylan Şekeroğlu, Ali Osman Saatçi
    Turkish Journal of Ophthalmology.2025; 55(6): 352.     CrossRef
  • Transcriptome Analyses of Liver Sinusoidal Endothelial Cells Reveal a Consistent List of Candidate Genes Associated with Endothelial Dysfunction and the Fibrosis Progression
    Penghui Li, Wenjie Xie, Hongjin Wei, Fan Yang, Yan Chen, Yinxiong Li
    Current Issues in Molecular Biology.2024; 46(8): 7997.     CrossRef
  • Correspondence to editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis”
    Jiaorong Qu, Le Wang, Xiaojiaoyang Li
    Clinical and Molecular Hepatology.2024; 30(4): 1002.     CrossRef
  • Unlocking the role of liver sinusoidal endothelial cells: Key players in liver fibrosis: Editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis”
    Yasuko Iwakiri
    Clinical and Molecular Hepatology.2024; 30(4): 673.     CrossRef
  • Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease
    Hui Gao, Yanchao Jiang, Ge Zeng, Nazmul Huda, Themis Thoudam, Zhihong Yang, Suthat Liangpunsakul, Jing Ma
    eGastroenterology.2024; 2(4): e100104.     CrossRef
  • Exploring the Role of Peroxisome Proliferator-Activated Receptors and Endothelial Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Ana Paula Madariaga Traconis, Misael Uribe-Esquivel, Varenka Julieta Barbero Becerra
    Cells.2024; 13(24): 2055.     CrossRef
  • Si-Wu-Tang improves liver fibrosis by restoring liver sinusoidal endothelial cell functionality and reducing communication with hepatic stellate cells
    Le Wang, Jiaorong Qu, Jianan Li, Xiaoyong Xue, Lingling Qin, Yufei Li, Yuanfeng Dou, Xiaohong Mu, Xiaojiaoyang Li
    Chinese Medicine.2024;[Epub]     CrossRef
  • 18,556 View
  • 475 Download
  • 44 Web of Science
  • Crossref

Liver fibrosis, cirrhosis, and portal hypertension

Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase
Yasuko Iwakiri
Clin Mol Hepatol 2015;21(4):319-325.
Published online December 24, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.4.319

The inducible form of nitric oxide synthase (iNOS) is expressed in hepatic cells in pathological conditions. Its induction is involved in the development of liver fibrosis, and thus iNOS could be a therapeutic target for liver fibrosis. This review summarizes the role of iNOS in liver fibrosis, focusing on 1) iNOS biology, 2) iNOS-expressing liver cells, 3) iNOS-related therapeutic strategies, and 4) future directions.

Citations

Citations to this article as recorded by  Crossref logo
  • Illuminating liver fibrosis: recent progress in the design and applications of highly sensitive fluorescent probes
    Yutong Lv, Zhe Ma, Yue Chong, Zhenlong Wang, Li Xue, Fu Wang
    Materials Horizons.2026; 13(1): 67.     CrossRef
  • Spermidine‐Based Carbon Quantum Dots Alleviate Liver Sinusoidal Endothelial Dysfunction by Inducing LSEC‐Derived NO to Ameliorate Hepatic Fibrosis and Portal Hypertension
    Jin‐Bo Zhao, Gu‐Qing Luo, Zheng‐Hao Wu, Jia‐Yun Lin, Chi‐Hao Zhang, Guang‐Bo Wu, Qiang Fan, Xiao‐Liang Qi, Hai‐Zhong Huo, Ji‐Wei Yu, Hong‐Jie Li, Meng Luo, Lei Zheng
    Advanced Healthcare Materials.2026;[Epub]     CrossRef
  • Metformin is associated with the suppression of the TNF-α/iNOS/TIMP-1 axis-mediated liver injury and fibrosis secondary to diabetes
    Hind Zafrah, Saif A. Alqahtani, Fahaid Al-Hashem, Bahjat Al-Ani, Nourah M. Alzamil
    Tissue and Cell.2026; 101: 103425.     CrossRef
  • Acute to chronic liver macrophage response in Syrian hamsters infected with the liver fluke Opisthorchis felineus
    Anna Kovner, Yaroslav Kapushchak, Ekaterina Medvedeva, Oxana Zaparina, Maria Pakharukova
    Acta Tropica.2026; 278: 108098.     CrossRef
  • Nitric oxide pathway: Emerging therapeutic strategies for MASLD
    Yanling Zhang, Ying Zhang, Hongjin Chen, Fangfang Qi
    Pathology - Research and Practice.2026; 284: 156516.     CrossRef
  • Gut dysbiosis and nitric oxide dysregulation in cirrhosis progression: mechanistic insights and pathophysiological implications
    Vlad Răzniceanu, Andra Țichindeleanu, Eugen-Valentin Răducu, Șerban Ellias Trella, Iuliana Nenu
    Journal of Physiology and Biochemistry.2026;[Epub]     CrossRef
  • Visualization of hepatic fibrosis and assessment of therapeutic effect by an asymmetric BODIPY fluorescent probe capable of dually detecting lipid droplets and nitric oxide
    Yue Wu, Lanqing Li, Lei Chen, Wen-Hua Chen
    Analytica Chimica Acta.2026; 1414: 345670.     CrossRef
  • Toxicity and Hepatoprotective Effects of ZnO Nanoparticles on Normal and High-Fat Diet-Fed Rat Livers: Mechanism of Action
    Fatemeh Mirzaei, Ebrahim Abbasi, Amir Mirzaei, Nashmin Fayazi Hosseini, Nima Naseri, Iraj Khodadadi, Cyrus Jalili, Nesrine Majdoub
    Biological Trace Element Research.2025; 203(1): 199.     CrossRef
  • Key role of macrophages in the progression of hepatic fibrosis
    Jinqiu Ran, Shengxia Yin, Rahma Issa, Qianwen Zhao, Guangqi Zhu, Huan Zhang, Qun Zhang, Chao Wu, Jie Li
    Hepatology Communications.2025;[Epub]     CrossRef
  • Exploring Extracellular Vesicles: A Novel Approach in Nonalcoholic Fatty Liver Disease
    Andrea del Pilar Abreo Medina, Mengdie Shi, Yanyan Wang, Zhongyu Wang, Kehe Huang, Yunhuan Liu
    Journal of Agricultural and Food Chemistry.2025; 73(5): 2717.     CrossRef
  • Sinusoidal communication in chronic liver disease
    Albert Gibert-Ramos, María Andrés-Rozas, Raül Pastó, Pablo Alfaro-Retamero, Sergi Guixé-Muntet, Jordi Gracia-Sancho
    Clinical and Molecular Hepatology.2025; 31(1): 32.     CrossRef
  • The role of liver sinusoidal endothelial cells in metabolic dysfunction-associated steatotic liver diseases and liver cancer: mechanisms and potential therapies
    Hanjun Mo, Pengfei Yue, Qiaoqi Li, Yinxi Tan, Xinran Yan, Xinyue Liu, Yuanwei Xu, Yingzhe Luo, Suruiya Palihati, Cheng Yi, Hua Zhang, Minlan Yuan, Biao Yang
    Angiogenesis.2025;[Epub]     CrossRef
  • Lipid Dysmetabolism in Canine Chronic Liver Disease: Relationship Between Clinical, Histological and Immunohistochemical Features
    Verena Habermaass, Yuki Takami, Takeshi Izawa, Francesca Abramo, Corrado Biolatti, Veronica Marchetti
    Veterinary Sciences.2025; 12(3): 220.     CrossRef
  • Propolis-loaded/dextrose˗coated bilosomes for enhanced protection against CCl4-induced liver injury: In vitro and in vivo assessments
    Reham Mokhtar Aman, Randa Ahmed Zaghloul, Noha Mohamed Saleh
    Journal of Drug Delivery Science and Technology.2025; 107: 106756.     CrossRef
  • Recent Progress in Small Molecule Fluorescent Probes for Imaging and Diagnosis of Liver Injury
    Shuo Liu, Fei Huang, Xinyi Huang, Fuxin Zhang, Dong Pei, Jinlong Zhang, Jun Hai
    Targets.2025; 3(2): 18.     CrossRef
  • Research Progress on Anti-fibrotic Effects and Mechanisms of Tetrandrine
    Ping Ma, Yu-ju Cai, Hui Dong, Ruo-lan Dong
    Chinese Journal of Integrative Medicine.2025; 31(9): 837.     CrossRef
  • The natural compounds derived from the plant Moquiniastrum polymorphum subsp. polymorphum prevent and treat liver fibrosis in vivo by reducing inflammation and fibrotic markers
    Matheus Scherer Bastos, Kétlin Fernanda Rodrigues, Maria Claudia Rosa Garcia, Carolina Luft, Giovana Vivan Tonial, Giovanna Mezzomo Pavanato, Leandro Vieira Astarita, Barbara Bettanin Gatti, Fábio Luiz Dal Moro Maito, Eliane Romanato Santarém, J.R. de Oli
    Toxicon.2025; 264: 108436.     CrossRef
  • Levistilide A attenuates carbon tetrachloride (CCl4)-induced liver fibrosis by inhibiting the NF-κB/iNOS/NO signalling pathway in M1 macrophages
    Rui Zeng, Liu Shen, Tingjie Ye, Wei Xu, Kai Huang, Fengjun Qiu, Chenghai Liu, Xudong Hu
    Journal of Ethnopharmacology.2025; 351: 120074.     CrossRef
  • Molecular Imaging Probes for Early Detection and Staging of Liver Fibrosis
    Xiuqi Hu, Mengdan Xu, Xiao Xiao, Ning Wang, Qianqian Zhang, Jianxian Ge, Jianfeng Zeng
    Chemical & Biomedical Imaging.2025; 3(11): 702.     CrossRef
  • Stearidonic Acid-Enriched Buglossoides arvensis Oil Alleviates High-Fat Diet-Induced Hepatic Lipid Accumulation and Inflammation via AMPK/SIRT1 Activation in Rats
    Mak-Soon Lee, Bohyeon Kim, Jumi Lee, Yejie Cho, In-Hwan Kim, Yangha Kim
    The Journal of Nutrition.2025; 155(10): 3401.     CrossRef
  • Lawsone can suppress liver fibrosis by inhibition of YAP signaling and induction of CYGB expression in hepatic stellate cells
    Atsuko Daikoku, Tsutomu Matsubara, Misako Sato-Matsubara, Miku Ando, Chiho Kadono, Sayuri Takada, Naoshi Odagiri, Hideto Yuasa, Hayato Urushima, Katsutoshi Yoshizato, Norifumi Kawada, Kazuo Ikeda
    Biomedicine & Pharmacotherapy.2025; 191: 118520.     CrossRef
  • SIRT1 in Aging and Diseases
    Altaf A. Abdulkhaliq, Glowi Alasiri, Johra Khan, Amir Ajoolabady, Jaakko Tuomilehto, Nils Henninger, Suhad Bahijri, Domenico Pratico, Anwar Borai, Bahauddeen M. Alrfaei, Bonglee Kim, Jun Ren
    Journal of Cellular Biochemistry.2025;[Epub]     CrossRef
  • Intravenous Lidocaine Modulates the Perioperative Hepatic Inflammatory Response: Implications for Personalized Medicine in Thoracic Surgery
    Ana Isabel Galve, Ignacio Garutti, Elena Vara, Guillermo González, Gabriel Cusati, Lisa Rancan, Luis Huerta, Javier Casanova, Carlos Simón
    Journal of Personalized Medicine.2025; 15(12): 620.     CrossRef
  • Organelle stress and alterations in interorganelle crosstalk during liver fibrosis
    Saloni Sinha, Nora Hassan, Robert E. Schwartz
    Hepatology.2024; 79(2): 482.     CrossRef
  • Baccharis anomala DC. extract reduces inflammation and attenuates hepatic fibrosis in vivo by decreasing NF-kB and extracellular matrix compounds
    Bruno de Souza Basso, Matheus Scherer Bastos, Géssica Luana Antunes, Lucas Strassburger Matzenbacher, Kétlin Fernanda Rodrigues, Maria Claudia Rosa Garcia, Arieli Cruz de Sousa, Vitor Giancarlo Levorse, Carolina Luft, Giovana Vivan Tonial, Giovanna Mezzom
    Toxicon.2024; 237: 107560.     CrossRef
  • Not just fibrotic: endothelial-derived TGFβ maintains contractile function and lymphatic muscle phenotype during homeostasis
    Miriam Carrillo Diaz de Leon, Keith Keane, Simon Roizes, Shan Liao, Pierre-Yves von der Weid, Matthew Stephens
    American Journal of Physiology-Cell Physiology.2024; 326(1): C269.     CrossRef
  • Thymoquinone protects thioacetamide‐induced chronic liver injury by inhibiting TGF‐β1/Smad3 axis in rats
    Subramanian Raghunandhakumar, Devaraj Ezhilarasan, Karthik Shree Harini
    Journal of Biochemical and Molecular Toxicology.2024;[Epub]     CrossRef
  • Potential i‐Nos/Arg‐1 Switch with NLRP3 and Parasitic Load Down Regulation in Experimental Schistosoma mansoni Infection via Chloroquine Repurposing
    Marwa A. Hasby Saad, Esraa G. El‐Saadi, Dareen A. Ali, Mona M. Watany, Mohammed M. Eid
    Parasite Immunology.2024;[Epub]     CrossRef
  • Bacteroides and NAFLD: pathophysiology and therapy
    Jun Zhang, Jing Zhou, Zheyun He, Hongshan Li
    Frontiers in Microbiology.2024;[Epub]     CrossRef
  • Regulatory disturbances in the dynamical signaling systems of $$Ca^{2+}$$ and NO in fibroblasts cause fibrotic disorders
    Ankit Kothiya, Neeru Adlakha
    Journal of Biological Physics.2024; 50(2): 229.     CrossRef
  • Nitric oxide donor S‐Nitroso‐N‐acetyl penicillamine for hepatic stellate cells to restore quiescence
    Junbao Du, Yin He, Wen Jia, Xiaohua Liang, Quan Kang, Yun He
    Pediatric Discovery.2024;[Epub]     CrossRef
  • Microarray analysis demonstrates up-regulation of the endothelin-1 gene with compensatory down-regulation of the ETA receptor gene in human portal vein
    Nicola E. Owen, Thomas L. Williams, Janet J. Maguire, Rhoda E. Kuc, Emma E. Davenport, Anthony P. Davenport
    Bioscience Reports.2024;[Epub]     CrossRef
  • Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems
    Jie Liu, Jinhu Liu, Weiwei Mu, Qingping Ma, Xiangyu Zhai, Bin Jin, Yongjun Liu, Na Zhang
    ACS Nano.2024; 18(32): 20861.     CrossRef
  • Correspondence to editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis”
    Jiaorong Qu, Le Wang, Xiaojiaoyang Li
    Clinical and Molecular Hepatology.2024; 30(4): 1002.     CrossRef
  • Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice
    Kyung Eun Kim, Jaewoong Lee, Hyun Joo Shin, Eun Ae Jeong, Hye Min Jang, Yu Jeong Ahn, Hyeong Seok An, Jong Youl Lee, Meong Cheol Shin, Soo Kyoung Kim, Won Gi Yoo, Won Ho Kim, Gu Seob Roh
    Hepatology.2023; 77(3): 888.     CrossRef
  • (Poly)phenols and nitrolipids: Relevant participants in nitric oxide metabolism
    César G. Fraga, Andrés Trostchansky, Barbara S. Rocha, João Laranjinha, Homero Rubbo, Monica Galleano
    Molecular Aspects of Medicine.2023; 89: 101158.     CrossRef
  • The evolving role of liver sinusoidal endothelial cells in liver health and disease
    Matthew J. McConnell, Enis Kostallari, Samar H. Ibrahim, Yasuko Iwakiri
    Hepatology.2023; 78(2): 649.     CrossRef
  • Nanodrug Delivery Systems for Metabolic Chronic Liver Diseases: Advances and Perspectives
    Foteini Athanasopoulou, Michail Manolakakis, Santiago Vernia, Nazila Kamaly
    Nanomedicine.2023; 18(1): 67.     CrossRef
  • The Role of Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl4-Induced Liver Fibrosis in Rats
    Diana K. Ghobrial, Nefertiti El-Nikhely, Eman Sheta, Hanan M. Ragab, Sherif A. F. Rostom, Hesham Saeed, Ahmed Wahid
    Antioxidants.2023; 12(3): 637.     CrossRef
  • Curcuma aromatica Salisb. Protects from Acetaminophen-Induced Hepatotoxicity by Regulating the Sirt1/HO-1 Signaling Pathway
    Hyunseong Kim, Jinyoung Hong, Junseon Lee, Wanjin Jeon, Changhwan Yeo, Yoonjae Lee, Seungho Baek, Inhyuk Ha
    Nutrients.2023; 15(4): 808.     CrossRef
  • Accurate diagnosis of hepatic fibrosis with dual detection of nitric oxide and viscosity by a ratiometric fluorescent probe
    Shaohui Han, Lei Yang, Miaomiao Liu, Haipu Li, Xiangzhi Song
    Chemical Engineering Journal.2023; 463: 142383.     CrossRef
  • The eNOS isoform exhibits increased expression and activation in the main olfactory bulb of nNOS knock-out mice
    David Pérez-Boyero, Carlos Hernández-Pérez, Jorge Valero, Valeria Lorena Cabedo, José Ramón Alonso, David Díaz, Eduardo Weruaga
    Frontiers in Cellular Neuroscience.2023;[Epub]     CrossRef
  • Congenital diaphragmatic hernia increases the sensitivity of pulmonary arteries to nitric oxide
    Alecsander F. Bressan, Victoria Oliveira Maia, Beatriz de Souza Rodrigues, Giuliana Bertozi, Sabrina S. Batah, Alexandre T. Fabro, Glória Pelizzo, Ugo Maria Pierucci, Rita C. Tostes, Lourenço Sbragia, Fernando S. Carneiro
    Pharmacological Research.2023; 191: 106749.     CrossRef
  • Vessel-on-a-Chip: A Powerful Tool for Investigating Endothelial COVID-19 Fingerprints
    Oksana Shevchuk, Svitlana Palii, Anastasiia Pak, Nuria Chantada, Nuria Seoane, Mykhaylo Korda, Manuel Campos-Toimil, Ezequiel Álvarez
    Cells.2023; 12(9): 1297.     CrossRef
  • Mexican Native Black Bean Anthocyanin-Rich Extracts Modulate Biological Markers Associated with Inflammation
    Jonhatan Contreras, Montserrat Alcázar-Valle, Eugenia Lugo-Cervantes, Diego A. Luna-Vital, Luis Mojica
    Pharmaceuticals.2023; 16(6): 874.     CrossRef
  • S-nitrosylation of EMMPRIN influences the migration of HSCs and MMP activity in liver fibrosis
    Xinyan Zhu, Zihui Tang, Wei Li, Xiaojuan Li, Yasuko Iwakiri, Fei Liu
    Acta Biochimica et Biophysica Sinica.2023; 55(10): 1640.     CrossRef
  • Eucalyptol Protects against Cisplatin-Induced Liver Injury in Rats
    Gokhan Akcakavak, Filiz Kazak, Mehmet Zeki Yilmaz Deveci
    Biology Bulletin.2023; 50(5): 987.     CrossRef
  • EASL-ERN position paper on liver involvement in patients with Fontan-type circulation
    Luis Téllez, Audrey Payancé, Eric Tjwa, María Jesús del Cerro, Lars Idorn, Stanislav Ovroutski, Ruth De Bruyne, Henkjan J. Verkade, Fabrizio De Rita, Charlotte de Lange, Annalisa Angelini, Valérie Paradis, Pierre Emmanuel Rautou, Juan Carlos García-Pagán
    Journal of Hepatology.2023; 79(5): 1270.     CrossRef
  • Schisandrin B Promotes Hepatic Stellate Cell Ferroptosis via Wnt Pathway-Mediated Ly6Clo Macrophages
    Xinmiao Li, Feng Jiang, Yuhang Hu, Zhichao Lang, Yating Zhan, Rongrong Zhang, Qiqi Tao, Chengchu Luo, Jinglu Yu, Jianjian Zheng
    Journal of Agricultural and Food Chemistry.2023;[Epub]     CrossRef
  • Ameliorative role of inducible nitric oxide synthase inhibitors against sodium arsenite-induced renal and hepatic dysfunction in rats
    Ashwani Kumar Sharma, Anmoldeep Kaur, Tajpreet Kaur, Sarabjit Kaur, Devendra Pathak, Amrit Pal Singh
    Drug and Chemical Toxicology.2022; 45(5): 2255.     CrossRef
  • G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases
    Nan Li, Shan Shan, Xiu-Qin Li, Ting-Ting Chen, Meng Qi, Sheng-Nan Zhang, Zi-Ying Wang, Ling-Ling Zhang, Wei Wei, Wu-Yi Sun
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Centella asiatica extract protects against cisplatin-induced hepatotoxicity via targeting oxidative stress, inflammation, and apoptosis
    Irmak Ferah Okkay, Ufuk Okkay, Ismail Cagri Aydin, Cemil Bayram, Muhammed Sait Ertugrul, Ali Sefa Mendil, Ahmet Hacimuftuoglu
    Environmental Science and Pollution Research.2022; 29(22): 33774.     CrossRef
  • 1,2,3,4,6-Penta-O-galloyl-d-glucose Interrupts the Early Adipocyte Lifecycle and Attenuates Adiposity and Hepatic Steatosis in Mice with Diet-Induced Obesity
    Ashish Rao Sathyanarayana, Chung-Kuang Lu, Chih-Chuang Liaw, Chia-Chuan Chang, Hsin-Ying Han, Brian D. Green, Wei-Jan Huang, Cheng Huang, Wen-Di He, Lin-Chien Lee, Hui-Kang Liu
    International Journal of Molecular Sciences.2022; 23(7): 4052.     CrossRef
  • Inhibitory effect of water-soluble mulberry leaf extract on hepatic lipid accumulation in high-fat diet-fed rats via modulation of hepatic microRNA-221/222 expression and inflammation
    Mak-Soon Lee, Cheamin Kim, Hyunmi Ko, Yangha Kim
    Journal of Nutrition and Health.2022; 55(2): 227.     CrossRef
  • Effect of Acrylamide Treatment on Cyp2e1 Expression and Redox Status in Rat Hepatocytes
    Jelena Marković Filipović, Marko Miler, Danijela Kojić, Jelena Karan, Ivana Ivelja, Jovana Čukuranović Kokoris, Milica Matavulj
    International Journal of Molecular Sciences.2022; 23(11): 6062.     CrossRef
  • Association of resveratrol with the suppression of TNF-α/NF-kB/iNOS/HIF-1α axis-mediated fibrosis and systemic hypertension in thioacetamide-induced liver injury
    Hasnaa A. Ebrahim, Samaa S. Kamar, Mohamed A. Haidara, Noha S. Abdel Latif, Mohamed Abd Ellatif, Asmaa M. ShamsEldeen, Bahjat Al-Ani, Amal F. Dawood
    Naunyn-Schmiedeberg's Archives of Pharmacology.2022; 395(9): 1087.     CrossRef
  • Is Glyceryl Trinitrate, a Nitric Oxide Donor Responsible for Ameliorating the Chemical-Induced Tissue Injury In Vivo?
    Ayesha Rahman Ahmed, Mahiba Ahmed, Senty Vun-Sang, Mohammad Iqbal
    Molecules.2022; 27(14): 4362.     CrossRef
  • Effect of nigella sativa oil on bisphenol a-induced hepatotoxicity in wistar albino rats: histopathological and biochemical investigation
    Mehmet Burak ATEŞ, Durmuş HATİPOĞLU
    International Journal of Agriculture Environment and Food Sciences.2022; 6(3): 402.     CrossRef
  • Mass spectrometry characterization of Commiphora leptophloeos leaf extract and preclinical evaluation of toxicity and anti-inflammatory potential effect
    Renato Dantas-Medeiros, Allanny Alves Furtado, Ana C. Zanatta, Manoela Torres-Rêgo, Estela Mariana Guimarães Lourenço, Jovelina Samara Ferreira Alves, Éder Galinari, Hugo Alexandre de Oliveira Rocha, Gerlane Coelho Bernardo Guerra, Wagner Vilegas, Thiago
    Journal of Ethnopharmacology.2021; 264: 113229.     CrossRef
  • Cyclic GMP in Liver Cirrhosis—Role in Pathophysiology of Portal Hypertension and Therapeutic Implications
    Wolfgang Kreisel, Adhara Lazaro, Jonel Trebicka, Markus Grosse Perdekamp, Annette Schmitt-Graeff, Peter Deibert
    International Journal of Molecular Sciences.2021; 22(19): 10372.     CrossRef
  • Expressions of heat shock protein 90, inducible nitric oxide synthase, and vascular endothelial growth factor in the skin of diabetic rats
    Khaled Z. Alawneh, Liqaa A. Raffee, Musa A. Alshehabat, Ahed Jumah Alkhatib
    Veterinary World.2021; : 1804.     CrossRef
  • An anti-DR5 antibody-curcumin conjugate for the enhanced clearance of activated hepatic stellate cells
    Van Quy Nguyen, Dong Gil You, Chan Ho Kim, Seunglee Kwon, Wooram Um, Byeong Hoon Oh, Jae Yoon An, Jueun Jeon, Jae Hyung Park
    International Journal of Biological Macromolecules.2021; 192: 1231.     CrossRef
  • Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation
    María José Rodríguez, Matías Sabaj, Gerardo Tolosa, Francisca Herrera Vielma, María José Zúñiga, Daniel R. González, Jessica Zúñiga-Hernández
    Cells.2021; 10(12): 3406.     CrossRef
  • Supplementation of Psidium Guajava Leaves Powder Prevents Hepatotoxicity and Inflammation in Carbon Tetrachloride (CCl4)-Administered Rats
    Nitol Debnath, Farzana B. Rafique, Nasrin Akhter, Anayt Ulla, Tahmina Yasmin, Md Nurul Islam, Md A. Alam
    Current Bioactive Compounds.2021; 17(4): 356.     CrossRef
  • High levels of dietary methionine improves sitagliptin-induced hepatotoxicity by attenuating oxidative stress in hypercholesterolemic rats
    Avinash Kumar, Rashmi Pathak, Henry A. Palfrey, Kirsten P. Stone, Thomas W. Gettys, Subramanyam N. Murthy
    Nutrition & Metabolism.2020;[Epub]     CrossRef
  • Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis
    Le Thi Thanh Thuy, Hoang Hai, Norifumi Kawada
    Clinical and Molecular Hepatology.2020; 26(3): 280.     CrossRef
  • Pituitary adenylate cyclase‐activating peptide: Potential roles in the pathophysiology and complications of cirrhosis
    Mads Barloese, Mohammadnavid Chitgar, Jens Hannibal, Søren Møller
    Liver International.2020; 40(11): 2578.     CrossRef
  • ROLE OF NITRIC OXIDE IN DEVELOPMENT OF FIBROTIC CHANGES IN RATS’ TESTES AFTER 270 DAY CENTRAL DEPRIVATION OF TESTOSTERONE SYNTHESIS
    Ye.V. Stetsuk, O.Ye. Akimov, K.V. Shepitko, N.V. Boruta, A.N. Goltsev
    World of Medicine and Biology.2020; 16(73): 211.     CrossRef
  • Синтропічні ураження серцево-судинної системи у хворих на цироз печінки: виелімінування; деякі патогенетичні механізми; характеристика й особливості; клінічні маркери, їх прогностична цінність; обґрунтування та ефективність модифікованого лікування
    М. Л. Фармага, М. О. Абрагамович, О. О. Абрагамович
    Lviv clinical bulletin.2020; (3 (31)): 8.     CrossRef
  • Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver
    Erika Ramos-Tovar, Pablo Muriel
    Antioxidants.2020; 9(12): 1279.     CrossRef
  • Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition
    Genta Kakiyama, Dalila Marques, Rebecca Martin, Hajime Takei, Daniel Rodriguez-Agudo, Sandra A. LaSalle, Taishi Hashiguchi, Xiaoying Liu, Richard Green, Sandra Erickson, Gregorio Gil, Michael Fuchs, Mitsuyoshi Suzuki, Tsuyoshi Murai, Hiroshi Nittono, Phil
    Journal of Lipid Research.2020; 61(12): 1629.     CrossRef
  • Antrodia Cinnamomea Attenuates Non-Alcoholic Steatohepatitis by Suppressing NLRP3 Inflammasome Activation In Vitro and In Vivo
    I-Chuan Yen, Jung-Chun Lin, Yu Chen, Qian-Wen Tu, Shih-Yu Lee
    The American Journal of Chinese Medicine.2020; 48(08): 1859.     CrossRef
  • Синтропічні ураження серцево-судинної системи у хворих на цироз печінки: виелімінування; деякі патогенетичні механізми; характеристика й особливості; клінічні маркери, їх прогностична цінність; обґрунтування та ефективність модифікованого лікування
    М. Л. Фармага, М. О. Абрагамович, О. О. Абрагамович, О. П. Фаюра, В. В. Чемес
    Lviv clinical bulletin.2020; (4 (32)): 8.     CrossRef
  • Modulation of inducible nitric oxide synthase pathway by eugenol and telmisartan in carbon tetrachloride-induced liver injury in rats
    Moustafa Fathy, Esraa M.M.A. Khalifa, Michael Atef Fawzy
    Life Sciences.2019; 216: 207.     CrossRef
  • Hepatic microcirculation and mechanisms of portal hypertension
    Jordi Gracia-Sancho, Giusi Marrone, Anabel Fernández-Iglesias
    Nature Reviews Gastroenterology & Hepatology.2019; 16(4): 221.     CrossRef
  • Molecular and Cellular Effect of Angiotensin 1–7 on Hypertensive Kidney Disease
    Yuanjian Chen, Wenyuan Zhao, Chang Liu, Weixin Meng, Tieqiang Zhao, Syamal K Bhattacharya, Yao Sun
    American Journal of Hypertension.2019; 32(5): 460.     CrossRef
  • Apoptosis perturbations and expression of regulatory inflammatory factors in cisplatin-depleted rat livers under l-arginine protection
    Rehab M. El-Sayed, Hebatalla I. Ahmed, Abd El-Lateef S. Abd El-Lateef, Azza A. Ali
    Canadian Journal of Physiology and Pharmacology.2019; 97(5): 359.     CrossRef
  • Green tea extract inhibits early oncogenic responses in mice with nonalcoholic steatohepatitis
    Priyankar Dey, Joshua B. Kim, Chureeporn Chitchumroonchokchai, Jinhui Li, Geoffrey Y. Sasaki, Bryan D. Olmstead, Katie L. Stock, Jennifer M. Thomas-Ahner, Steven K. Clinton, Richard S. Bruno
    Food & Function.2019; 10(10): 6351.     CrossRef
  • mTORC1-mediated polarization of M1 macrophages and their accumulation in the liver correlate with immunopathology in fatal ehrlichiosis
    Mohamed Haloul, Edson R. A. Oliveira, Muhamuda Kader, Jakob Z. Wells, Tyler R. Tominello, Abdeljabar El Andaloussi, Cecelia C. Yates, Nahed Ismail
    Scientific Reports.2019;[Epub]     CrossRef
  • Proteomic-genomic adjustments and their confluence for elucidation of pathways and networks during liver fibrosis
    Hadiya Husain, Riaz Ahmad, Anish Khan, Inamuddin, Abdullah M. Asiri
    International Journal of Biological Macromolecules.2018; 111: 379.     CrossRef
  • Improved hepatic γ-tocopherol status limits oxidative and inflammatory stress-mediated liver injury in db/db mice with nonalcoholic steatohepatitis
    Priyankar Dey, Eunice Mah, Jinhui Li, Thunder Jalili, J. David Symons, Richard S. Bruno
    Journal of Functional Foods.2018; 40: 670.     CrossRef
  • Thiamethoxam induced hepatotoxicity and pro-carcinogenicity in rabbits via motivation of oxidative stress, inflammation, and anti-apoptotic pathway
    Osama S. El Okle, Omnia I. El Euony, Asmaa F. Khafaga, Mohamed A. Lebda
    Environmental Science and Pollution Research.2018; 25(5): 4678.     CrossRef
  • SKLB023 hinders renal interstitial fibrosis in obstructive nephropathy by interfering TGF-β1/Smad3 signaling
    Yanhuan Feng, Jun Xu, Fan Guo, Rongshuang Huang, Min Shi, Lingzhi Li, Liang Ma, Ping Fu
    RSC Advances.2018; 8(11): 5891.     CrossRef
  • SKLB023 as an iNOS inhibitor alleviated liver fibrosis by inhibiting the TGF-beta/Smad signaling pathway
    Jinhang Zhang, Yanping Li, Qinhui Liu, Rui Li, Shiyun Pu, Lina Yang, Yanhuan Feng, Liang Ma
    RSC Advances.2018; 8(54): 30919.     CrossRef
  • A new diethylcarbamazine formulation (NANO-DEC) as a therapeutic tool for hepatic fibrosis
    Gabriel Barros Rodrigues, Elquio Eleamen Oliveira, Francisco Jaime Bezerra Mendonça Junior, Laise Aline Martins dos Santos, Wilma Helena de Oliveira, Maria Eduarda Rocha de França, Deniele Bezerra Lós, Brennda Martins Gabínio, Christina Alves Peixoto
    International Immunopharmacology.2018; 64: 280.     CrossRef
  • Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension
    Denise Schaffner, Adhara Lazaro, Peter Deibert, Peter Hasselblatt, Patrick Stoll, Lisa Fauth, Manfred W Baumstark, Irmgard Merfort, Annette Schmitt-Graeff, Wolfgang Kreisel
    World Journal of Gastroenterology.2018; 24(38): 4356.     CrossRef
  • Angiotensin II: a key mediator in the development of liver fibrosis and cancer
    Sameh Saber
    Bulletin of the National Research Centre.2018;[Epub]     CrossRef
  • PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway
    Brigitte Grouix, Francois Sarra-Bournet, Martin Leduc, Jean-Christophe Simard, Kathy Hince, Lilianne Geerts, Alexandra Blais, Liette Gervais, Alexandre Laverdure, Alexandra Felton, Jonathan Richard, Jugurtha Ouboudinar, William Gagnon, François A. Leblond
    The Journal of Pharmacology and Experimental Therapeutics.2018; 367(1): 71.     CrossRef
  • Reversal of liver cirrhosis: current evidence and expectations
    Young Kul Jung, Hyung Joon Yim
    The Korean Journal of Internal Medicine.2017; 32(2): 213.     CrossRef
  • Key role of liver sinusoidal endothelial cells in liver fibrosis
    Mingxing Xu, Xuehua Wang, Yong Zou, Yuesi Zhong
    BioScience Trends.2017; 11(2): 163.     CrossRef
  • Characterization and evaluation of nanoencapsulated diethylcarbamazine in model of acute hepatic inflammation
    Gabriel Barros Rodrigues, Elquio Eleamen Oliveira, Francisco Jaime Bezerra Mendonça Junior, Laise Aline Martins dos Santos, Wilma Helena de Oliveira, Maria Eduarda Rocha de França, Deniele Bezerra Lós, Brennda Martins Gabínio, Fábia Cristiane Melo Leite d
    International Immunopharmacology.2017; 50: 330.     CrossRef
  • Transforming growth factor-β1, connective tissue growth factor, and inducible nitric oxide synthesase in hepatitis C-positive chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma in Upper Egypt
    Yasser Gamal, Ahlam Badawy
    Egyptian Journal of Pathology.2017; 37(1): 128.     CrossRef
  • Mechanosensing in liver regeneration
    Ziwei Song, Kapish Gupta, Inn Chuan Ng, Jiangwa Xing, Yi An Yang, Hanry Yu
    Seminars in Cell & Developmental Biology.2017; 71: 153.     CrossRef
  • Early PQQ supplementation has persistent long‐term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice
    Karen R. Jonscher, Michael S. Stewart, Alba Alfonso‐Garcia, Brian C. DeFelice, Xiaoxin X. Wang, Yuhuan Luo, Moshe Levi, Margaret J. R. Heerwagen, Rachel C. Janssen, Becky A. de la Houssaye, Ellen Wiitala, Garrett Florey, Raleigh L. Jonscher, Eric O. Potma
    The FASEB Journal.2017; 31(4): 1434.     CrossRef
  • Уміст деяких вазоактивних гуморально- метаболічних чинників у хворих на цироз печінки та їх участь у патоґенезі коморбідних синтропічних уражень системи кровообігу
    М. О. Абрагамович, О. О. Абрагамович, М. Л. Фармага
    Lviv clinical bulletin.2017; (4 (20)): 40.     CrossRef
  • The 5-HT1A Agonist Buspirone Decreases Liver Oxidative Stress and Exerts Protective Effect Against CCl4– Toxicity
    Omar M.E. Abdel-Salam, Nermeen M. Shaffie, Nadia A. Mohammed, Eman R. Youness, Safaa M. Youssef Morsy, Amany A Sleem, Wei Wu
    Journal of Experimental and Clinical Toxicology.2017; 1(1): 13.     CrossRef
  • Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway
    Li Xuanfei, Chen Hao, Yi Zhujun, Liu Yanming, Gong Jianping
    Oncotarget.2017; 8(13): 21015.     CrossRef
  • Характеристика та особливості стану системи кровообігу у хворих на цироз печінки як хвороби з поліорґанним ураженням: патоґенез; діаґностика; принципи лікування її уражень (огляд літератури та опис клінічного випадку)
    М. Л. Фармага, М. О. Абрагамович, М. Р. Ферко
    Lviv clinical bulletin.2017; (2-3(18-19)): 53.     CrossRef
  • In vitro anti-hydatic and immunomodulatory effects of ginger and [6]-gingerol
    Manel Amri, Chafia Touil-Boukoffa
    Asian Pacific Journal of Tropical Medicine.2016; 9(8): 749.     CrossRef
  • Hepatic injury associated with Trypanosoma cruzi infection is attenuated by treatment with 15-deoxy-Δ 12,14 prostaglandin J 2
    Federico Nicolás Penas, Ágata Carolina Cevey, Sofía Siffo, Gerardo Ariel Mirkin, Nora Beatriz Goren
    Experimental Parasitology.2016; 170: 100.     CrossRef
  • Anti-inflammatory effect of zaluzanin C on lipopolysaccharide-stimulated murine macrophages
    Ye Rim Kang, Hee Won Lee, Yoon Hee Kim
    Korean Journal of Food Science and Technology.2016; 48(4): 392.     CrossRef
  • Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis
    Benjamin Lelouvier, Florence Servant, Sandrine Païssé, Anne‐Claire Brunet, Salah Benyahya, Matteo Serino, Carine Valle, Maria Rosa Ortiz, Josep Puig, Michael Courtney, Massimo Federici, José‐Manuel Fernández‐Real, Rémy Burcelin, Jacques Amar
    Hepatology.2016; 64(6): 2015.     CrossRef
  • 16,953 View
  • 276 Download
  • 92 Web of Science
  • Crossref
Hemodynamic alterations in cirrhosis and portal hypertension
Moon Young Kim, Soon Koo Baik, Samuel S. Lee
Korean J Hepatol 2010;16(4):347-352.
Published online December 31, 2010
DOI: https://doi.org/10.3350/kjhep.2010.16.4.347

Portal hypertension (PHT) is associated with hemodynamic changes in intrahepatic, systemic, and portosystemic collateral circulation. Increased intrahepatic resistance and hyperdynamic circulatory alterations with expansion of collateral circulation play a central role in the pathogenesis of PHT. PHT is also characterized by changes in vascular structure, termed vascular remodeling, which is an adaptive response of the vessel wall that occurs in response to chronic changes in the environment such as shear stress. Angiogenesis, the formation of new blood vessels, also occurs with PHT related in particular to the expansion of portosystemic collateral circulation. The complementary processes of vasoreactivity, vascular remodeling, and angiogenesis represent important targets for the treatment of portal hypertension. Systemic and splanchnic vasodilatation can induce hyperdynamic circulation which is related with multi-organ failure such as hepatorenal syndrome and cirrhotic cadiomyopathy.

Citations

Citations to this article as recorded by  Crossref logo
  • The value of low-energy images combined with deep learning image reconstruction to improve image quality, reduce radiation and contrast doses in dual-energy computed tomography (CT) portal venography in cirrhotic patients
    M. Li, Y. Jia, L. Fan, D. Han, D. Zhang, J. Fan, N. Yu, Y. Yu, Y. Yan
    Clinical Radiology.2026; 92: 107139.     CrossRef
  • Redox Imbalance in the Cardiohepatic Syndrome: The Emerging Role of Oxidative Stress in Cirrhosis-Associated Cardiac Dysfunction
    Nikola Blagojevic, Dragana Blagojevic, Ana Matovic, Marko Cvrkotic, Marija Marjanovic-Haljilji, Aleksandra Sljivic, Ana Ilic, Natasa Cvetinovic, Irina Nenadic, Marko Djuric, Nemanja Dimic, Milica Aleksic, Jovana Bojicic, Aleksandra Djokovic, Snezana Lukic
    Antioxidants.2026; 15(4): 490.     CrossRef
  • Lumped parameter modeling of changes in liver hemodynamics due to cirrhosis
    Edith Luveina Joseph, Himanshi Saini, Usha Kini, Timothy L. Pruett, Joseph Sushil Rao, Jeffrey Tithof
    Biomechanics and Modeling in Mechanobiology.2026;[Epub]     CrossRef
  • Portal Hypertension—Noninvasive Multiparametric Ultrasound‐Based Criteria and Measurements
    Kathleen Möller, Riyad Abu El Hija, Xiaolong Qi, Christian Jenssen, Sven Mutze, Burkhard Möller, Benjamin Misselwitz, Christoph F. Dietrich
    Portal Hypertension & Cirrhosis.2025; 4(1): 44.     CrossRef
  • Understanding acute kidney injury in cirrhosis: Current perspective
    Sayan Malakar, Sumit Rungta, Arghya Samanta, Umair Shamsul Hoda, Piyush Mishra, Gaurav Pande, Akash Roy, Suprabhat Giri, Praveer Rai, Samir Mohindra, Uday C Ghoshal
    World Journal of Hepatology.2025;[Epub]     CrossRef
  • The interplay between lymphatic system and portal hypertension: a comprehensive review
    Pinky Juneja, Rajni Yadav, Dinesh M. Tripathi, Savneet Kaur
    Hepatology International.2025; 19(4): 720.     CrossRef
  • Association of Estimated Plasma Volume Status With Invasive Hemodynamics and All‐Cause Mortality in Patients With Liver Cirrhosis
    Esteban Kosak Lopez, Phuuwadith Wattanachayakul, Jose Manuel Martinez Manzano, Andrew Geller, Simone A. Jarrett, John Malin, Raul Leguizamon, Tara A. John, Rasha Khan, Ian McLaren, Alexander Prendergast, Kevin Bryan Lo, Zurab Azmaiparashvili
    JGH Open.2025;[Epub]     CrossRef
  • Liver and systemic hemodynamics in cirrhotic children
    Roberto Tambucci, Xavier Stephenne, Aniss Channaoui, Catherine de Magnée
    World Journal of Hepatology.2025;[Epub]     CrossRef
  • Research on the Predictive Value of VAST Score for Significant Liver Failure after Right Hemihepatectomy for Hepatocellular Carcinoma
    玉敏 张
    Advances in Clinical Medicine.2025; 15(08): 306.     CrossRef
  • Cirrhotic Cardiomyopathy: Bridging Hepatic and Cardiac Pathophysiology in the Modern Era
    Dragoș Lupu, Camelia Cornelia Scârneciu, Diana Țînț, Cristina Tudoran
    Journal of Clinical Medicine.2025; 14(17): 5993.     CrossRef
  • Principles of Non-selective Beta-blocker Usage for Cirrhosis-associated Complications
    Daisy K. Maclaine, Kosha J. Mehta
    SN Comprehensive Clinical Medicine.2025;[Epub]     CrossRef
  • Serum lactate and mean arterial pressure thresholds in patients with cirrhosis and septic shock
    Thomas N. Smith, Chansong Choi, Puru Rattan, Laura Piccolo Serafim, Blake A. Kassmeyer, Ryan J. Lennon, Ognjen Gajic, Jody C. Olson, Patrick S. Kamath, Alice Gallo De Moraes, Douglas A. Simonetto
    Hepatology Communications.2024;[Epub]     CrossRef
  • Can Plasma Volume Determination in Cirrhosis Be Replaced by an Algorithm Using Body Weight and Hematocrit?
    Martine Prütz Nørskov, Thormod Mønsted, Nina Kimer, Morten Damgaard, Søren Møller
    Diagnostics.2024; 14(8): 835.     CrossRef
  • Liver Fibrosis Leading to Cirrhosis: Basic Mechanisms and Clinical Perspectives
    Kaumudi Somnay, Priyanka Wadgaonkar, Nidhishri Sridhar, Prarath Roshni, Nachiketh Rao, Raj Wadgaonkar
    Biomedicines.2024; 12(10): 2229.     CrossRef
  • Histological features of the structure of the portal vein of the liver and splenic vein in portal hypertension
    Sergey V. Minaev, Natalia V. Getman, Alina N. Grigorova, Sergey S. Dydykin, Olga B. Sumkina, Sergey I. Timofeev
    Morphology.2023; 160(1): 37.     CrossRef
  • Monitoring the effects of automated gas control of sevoflurane versus target-guided propofol infusion on hemodynamics of liver patients during liver resection. A randomized controlled trial
    Yasmeen Abdelsalam Kamel, Noura Adel Ghareeb Sasa, Safaa Mohamed Helal, Hatem Amin Attallah, Khaled A. Yassen
    Journal of Anaesthesiology Clinical Pharmacology.2023; 39(1): 74.     CrossRef
  • Early Mortality After Emergency Transarterial Embolization/Chemoembolization for Spontaneous Rupture of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
    Chao Ma, Yan Wang, Xiao-Hui Li, Feng Duan
    Iranian Journal of Radiology.2023;[Epub]     CrossRef
  • Esophageal and stomach varices: physiological and anatomical features of formation
    S. M. Chooklin, S. S. Chuklin, M. M. Posivnych, S. A. Krystopchuk
    The Ukrainian Journal of Clinical Surgery.2023; 90(1): 57.     CrossRef
  • Laparoscopic Splenectomy and Esophagogastric Devascularization Versus Endoscopic Varices Ligation Plus Laparoscopic Splenectomy in the Treatment of Portal Hypertension
    Rui Cao, Xiangyu Lu, Yilei Wu, Siyu Li, Jun Gong
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2023; 33(11): 1052.     CrossRef
  • Hemodynamic Changes in Chronic Liver Disease
    Sangyong Jo, Kyungil Park
    The Korean Journal of Gastroenterology.2023; 82(5): 209.     CrossRef
  • Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis—Pathogenesis, Implications and Therapeutic Opportunities
    Ryma Terbah, Adam Testro, Paul Gow, Avik Majumdar, Marie Sinclair
    Nutrients.2023; 16(1): 35.     CrossRef
  • Management of upper gastrointestinal bleeding in advanced hepatocellular carcinoma with portal hypertension and variceal bleeding during receiving tyrosine kinase inhibitors therapy: Beyond and known frontiers
    Zheng Song, Xiujuan Chang, Yongping Yang
    Liver Cancer International.2023; 4(3-4): 127.     CrossRef
  • Morphological aspects of the normal versus pathological liver
    A. Chesca, N. Shambilova
    Medicine and ecology.2023; (4): 53.     CrossRef
  • Ultrasound Pressure Estimation for Diagnosing Portal Hypertension in Patients Undergoing Dialysis for Chronic Kidney Disease
    Priscilla Machado, Ipshita Gupta, Jonathan M. Fenkel, Sriharsha Gummadi, Maria Stanczak, Corinne E. Wessner, Colette M. Shaw, Susan Schultz, Michael C. Soulen, Kirk Wallace, John R. Eisenbrey, Flemming Forsberg
    Journal of Ultrasound in Medicine.2022; 41(9): 2181.     CrossRef
  • The impact of cirrhosis on the postoperative outcomes of patients undergoing splenectomy: Propensity score matched analysis of the 2011–2017 US hospital database
    David U. Lee, Gregory H. Fan, David J. Hastie, Elyse A. Addonizio, Raffi Karagozian
    Scandinavian Journal of Surgery.2022;[Epub]     CrossRef
  • Study on the Mechanism of Blood Circulation in Patients with Liver Fibrosis
    莉 田
    Advances in Clinical Medicine.2022; 12(11): 9816.     CrossRef
  • Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma
    Bohyun Kim, Soon Sun Kim, Sung Won Cho, Jae Youn Cheong, Jimi Huh, Jai Keun Kim, Jei Hee Lee, Hye Ri Ahn, Hyo Jung Cho
    European Radiology.2021; 31(4): 2507.     CrossRef
  • Hepatic Vein Contrast-Enhanced Ultrasound Subharmonic Imaging Signal as a Screening Test for Portal Hypertension
    Priscilla Machado, Ipshita Gupta, Sriharsha Gummadi, Maria Stanczak, Corinne E. Wessner, Jonathan M. Fenkel, Colette M. Shaw, Susan Shamini-Noori, Susan Schultz, Michael C. Soulen, Chandra M. Sehgal, Kirk Wallace, John R. Eisenbrey, Flemming Forsberg
    Digestive Diseases and Sciences.2021; 66(12): 4354.     CrossRef
  • The Clinical Impact of Cirrhosis on the Hospital Outcomes of Patients Admitted With Influenza Infection: Propensity Score Matched Analysis of 2011–2017 US Hospital Data
    David U. Lee, Gregory H. Fan, David J. Hastie, Vibhav N. Prakasam, Elyse A. Addonizio, Ryan R. Ahern, Kristen J. Seog, Raffi Karagozian
    Journal of Clinical and Experimental Hepatology.2021; 11(5): 531.     CrossRef
  • The Association Between Hepatic Venous Pressure Gradient Baseline and the Response Rate of Carvedilol on Portal Hypertension
    Lifen Wang, Qian Ding, Xueying Wang, Xiangguo Tian, Guangchuan Wang, Chunqing Zhang
    Hepatitis Monthly.2021;[Epub]     CrossRef
  • β-blockers in advanced cirrhosis: More friend than enemy
    Ki Tae Yoon, Hongqun Liu, Samuel S. Lee
    Clinical and Molecular Hepatology.2021; 27(3): 425.     CrossRef
  • Hepatopulmonary syndrome is related to the development of acute-on-chronic liver failure and poor prognosis in cirrhotic patients
    Seul Ki Han, Moon Young Kim, Seong Hee Kang, Ki Tae Suk, Soon Koo Baik
    Hepatology International.2021; 15(5): 1207.     CrossRef
  • Mechanisms in fluid retention – towards a mutual concept
    Mathis N. Mottelson, Christoffer C. Lundsgaard, Søren Møller
    Clinical Physiology and Functional Imaging.2020; 40(2): 67.     CrossRef
  • Bioengineered 3D Models to Recapitulate Tissue Fibrosis
    Marta Sacchi, Ruchi Bansal, Jeroen Rouwkema
    Trends in Biotechnology.2020; 38(6): 623.     CrossRef
  • Effect of direct-acting antivirals on corrected QT interval and cardiac functions in patients with chronic hepatitis C virus infection
    Mohamed Gamal Ibrahim, Ahmed Abdelrahman Sharafeldin, Nevine Ibrahim Mousa, Tarek Khairy Mousa, Ahmed Mohamed El Missiri
    The Egyptian Heart Journal.2020;[Epub]     CrossRef
  • Cirrhotic Cardiomyopathy
    Ki Tae Yoon, Hongqun Liu, Samuel S. Lee
    Current Gastroenterology Reports.2020;[Epub]     CrossRef
  • Hemodynamic Changes of Hepatic & Renal Vessels in Systemic Bacterial Infection with Fever in HCV Related Cirrhosis
    Eman Mohammed Helal, Mohamed Sharaf-Eldin, Abdel Raouf Abou El Azm, Nagwa Mansour Badr Eldin, Mohammed Mahmoud Dawoud , Sherief Abd-Elsalam, Dina Hazem Ziada
    Infectious Disorders - Drug Targets .2020; 20(4): 511.     CrossRef
  • Labile heme impairs hepatic microcirculation and promotes hepatic injury
    Franziska A. Englert, Raphael A. Seidel, Kerstin Galler, Zelia Gouveia, Miguel P. Soares, Ute Neugebauer, Mark G. Clemens, Christoph Sponholz, Stefan H. Heinemann, Georg Pohnert, Michael Bauer, Sebastian Weis
    Archives of Biochemistry and Biophysics.2019; 672: 108075.     CrossRef
  • Carvedilol Inhibits Angiotensin II-Induced Proliferation and Contraction in Hepatic Stellate Cells through the RhoA/Rho-Kinase Pathway
    Ying Wu, Zhen Li, Sining Wang, Aiyuan Xiu, Chunqing Zhang
    BioMed Research International.2019; 2019: 1.     CrossRef
  • Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma
    Jin Woo Choi, Jin Wook Chung, Dong Ho Lee, Hyo-Cheol Kim, Saebeom Hur, Myungsu Lee, Hwan Jun Jae
    European Radiology.2018; 28(5): 2184.     CrossRef
  • Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments
    Zhimin Liu, Zhifeng Zhang, Mei Huang, Xiaoping Sun, Bojia Liu, Qiyang Guo, Qingshan Chang, Zhijun Duan
    BMC Gastroenterology.2018;[Epub]     CrossRef
  • A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock
    Ashok Choudhury, Chandan K. Kedarisetty, Chitranshu Vashishtha, Deepak Saini, Sachin Kumar, Rakhi Maiwall, Manoj K. Sharma, Ajeet S. Bhadoria, Guresh Kumar, Yogendra K. Joshi, Shiv K. Sarin
    Liver International.2017; 37(4): 552.     CrossRef
  • Hepatic vein transit time of second-generation ultrasound contrast agent: new tool in the assessment of portal hypertension
    Siciliani Luisa, Giovanna Vitale, Anna Rita Sorbo, Pompili Maurizio, Rapaccini Gian Lodovico
    Journal of Ultrasound.2017; 20(1): 43.     CrossRef
  • Dual-Energy CT in Focal and Diffuse Liver Disease
    Anushri Parakh, Vinit Baliyan, Dushyant V. Sahani
    Current Radiology Reports.2017;[Epub]     CrossRef
  • Renin angiotensin system in liver diseases: Friend or foe?
    Ana Cristina Simões e Silva, Aline S Miranda, Natália P Rocha, Antônio L Teixeira
    World Journal of Gastroenterology.2017; 23(19): 3396.     CrossRef
  • Glutamine prevents oxidative stress in a model of portal hypertension
    Gilmara Pandolfo Zabot, Gustavo Franco Carvalhal, Norma Possa Marroni, Francielli Licks, Renata Minuzzo Hartmann, Vinícius Duval da Silva, Henrique Sarubbi Fillmann
    World Journal of Gastroenterology.2017; 23(25): 4529.     CrossRef
  • Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study
    Yoo Li Lim, Moon Young Kim, Yoon Ok Jang, Soon Koo Baik, Sang Ok Kwon
    Gut and Liver.2017; 11(5): 702.     CrossRef
  • Liver and systemic hemodynamics in children with cirrhosis: Impact on the surgical management in pediatric living donor liver transplantation
    Catherine de Magnée, Francis Veyckemans, Thierry Pirotte, Renaud Menten, Dana Dumitriu, Philippe Clapuyt, Karlien Carbonez, Catherine Barrea, Thierry Sluysmans, Christine Sempoux, Isabelle Leclercq, Francis Zech, Xavier Stephenne, Raymond Reding
    Liver Transplantation.2017; 23(11): 1440.     CrossRef
  • Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis
    Yoo Li Lim, Eunhee Choi, Yoon Ok Jang, Youn Zoo Cho, Yong Seok Kang, Soon Koo Baik, Sang Ok Kwon, Moon Young Kim
    Gut and Liver.2016; 10(1): 109.     CrossRef
  • Neutrophil-to-Lymphocyte Ratio Predicts Early Mortality in Patients with HBV-Related Decompensated Cirrhosis
    Honggang Zhang, Qinqin Sun, Weilin Mao, Jian Fan, Bo Ye
    Gastroenterology Research and Practice.2016; 2016: 1.     CrossRef
  • AST to Platelet Ratio Index Predicts Mortality in Hospitalized Patients With Hepatitis B-Related Decompensated Cirrhosis
    Weilin Mao, Qinqin Sun, Jian Fan, Sha Lin, Bo Ye
    Medicine.2016; 95(9): e2946.     CrossRef
  • Dysregulated apoptosis of the venous wall in chronic venous disease and portal hypertension
    Li Kun, Li Ying, Wang Lei, Zhao Jianhua, Xu Yongbo, Wang Tao, Tang Jinyuan, Chu Haibo
    Phlebology: The Journal of Venous Disease.2016; 31(10): 729.     CrossRef
  • Sodium Ferulate Reduces Portal Pressure Through Inhibition of RhoA/Rho-Kinase and Activation of Endothelial Nitric Oxide Synthase in Cirrhotic Rats
    Jiqiao Liu, Liping Peng, Juan Yang, Min Wang, Shengnan Xu, Jingmei Liu, Ping Han, Jiayi He, Dean Tian, Qi Zhou
    Digestive Diseases and Sciences.2015; 60(7): 2019.     CrossRef
  • Portal hypertension: a review of portosystemic collateral pathways and endovascular interventions
    A.K. Pillai, B. Andring, A. Patel, C. Trimmer, S.P. Kalva
    Clinical Radiology.2015; 70(10): 1047.     CrossRef
  • Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction
    Louise Madeleine Risør, Flemming Bendtsen, Søren Møller
    Hepatology International.2015; 9(1): 17.     CrossRef
  • Characterization of uncommon portosystemic collateral circulations in patients with hepatic cirrhosis
    QIN WU, LIJUN SHEN, JINDONG CHU, XUEMEI MA, BO JIN, FANPING MENG, JINPIN CHEN, YANLING WANG, LIBING WU, JUN HAN, WENHUI ZHANG, WEI MA, HUAMING WANG, HANWEI LI
    Oncology Letters.2015; 9(1): 347.     CrossRef
  • B-cell–associated immune profiles in patients with decompensated cirrhosis
    Joo Yeon Jhun, Hee Yeon Kim, Jae Kyeong Byun, Byung Ha Chung, Si Hyun Bae, Seung Kew Yoon, Dong Goo Kim, Chul Woo Yang, Mi-La Cho, Jong Young Choi
    Scandinavian Journal of Gastroenterology.2015; 50(7): 884.     CrossRef
  • Mesenteric artery responsiveness to acetylcholine and phenylephrine in cirrhotic rats challenged with endotoxin: the role of TLR4
    Sattar Ostadhadi, Seyed-Mahdi Rezayat, Shahram Ejtemaei-Mehr, Seyed-Mohammad Tavangar, Vahid Nikoui, Farahnaz Jazaeri, Golnar Eftekhari, Alireza Abdollahi, Ahmad-Reza Dehpour
    Canadian Journal of Physiology and Pharmacology.2015; 93(6): 475.     CrossRef
  • Severe Portal Hypertension in Cirrhosis: Evaluation of Perfusion Parameters with Contrast-Enhanced Ultrasonography
    Woo Kyoung Jeong, Tae Yeob Kim, Joo Hyun Sohn, Yongsoo Kim, Jinoo Kim, Chen-Hua Liu
    PLOS ONE.2015; 10(3): e0121601.     CrossRef
  • The influence that hepatic cirrhosis provides in exercise capacity and muscle strength: a review
    Renata Lopes Krüger, Bruno Costa Teixeira, Alexandre Simões Dias, Álvaro Reischak-Oliveira
    Fisioterapia em Movimento.2015; 28(3): 617.     CrossRef
  • Contrast-enhanced ultrasound for quantitative assessment of portal pressure in canine liver fibrosis
    Lin Zhai, Lan-Yan Qiu, Yuan Zu, Yan Yan, Xiao-Zhuan Ren, Jun-Feng Zhao, Yu-Jiang Liu, Ji-Bin Liu, Lin-Xue Qian
    World Journal of Gastroenterology.2015; 21(15): 4509.     CrossRef
  • Relationship between Tetrahydrobiopterin and Portal Hypertension in Patients with Chronic Liver Disease
    Won Ki Hong, Kwang Yong Shim, Soon Koo Baik, Moon Young Kim, Mee Yon Cho, Yoon Ok Jang, Young Shik Park, Jin Han, Gaeun Kim, Youn Zoo Cho, Hye Won Hwang, Jin Hyung Lee, Myeong Hun Chae, Sang Ok Kwon
    Journal of Korean Medical Science.2014; 29(3): 392.     CrossRef
  • Pathophysiology of Portal Hypertension
    Yasuko Iwakiri
    Clinics in Liver Disease.2014; 18(2): 281.     CrossRef
  • Review article: the endocannabinoid system in liver disease, a potential therapeutic target
    P. P. Basu, M. M. Aloysius, N. J. Shah, R. S. Brown Jr
    Alimentary Pharmacology & Therapeutics.2014; 39(8): 790.     CrossRef
  • The role of chemokines in acute and chronic hepatitis C infection
    Stephen Fahey, Eugene Dempsey, Aideen Long
    Cellular & Molecular Immunology.2014; 11(1): 25.     CrossRef
  • Laparoscopic Versus Open Splenectomy for Portal Hypertension
    Yunqiang Cai, Zhihong Liu, Xubao Liu
    Surgical Innovation.2014; 21(4): 442.     CrossRef
  • Effect of portal vein ligation on tumor growth and liver regeneration in rat cirrhotic liver lobes
    RUI XU, YU-FENG YUAN, AHMET AYAV, CHONG-QING JIANG, LAURENT BRESLER, ZHI-SU LIU, NGUYEN TRAN
    Experimental and Therapeutic Medicine.2014; 7(5): 1089.     CrossRef
  • Sodium ferulate lowers portal pressure in rats with secondary biliary cirrhosis through the RhoA/Rho-kinase signaling pathway: A preliminary study
    LAI WEI, JUAN YANG, MIN WANG, SHENG-NAN XU, HUA-MIN LIANG, QI ZHOU
    International Journal of Molecular Medicine.2014; 34(5): 1257.     CrossRef
  • ANG II receptor subtype 1a gene knockdown in the subfornical organ prevents increased drinking behavior in bile duct-ligated rats
    Joseph D. Walch, T. Prashant Nedungadi, J. Thomas Cunningham
    American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.2014; 307(6): R597.     CrossRef
  • The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data
    Won Ki Hong, Moon Young Kim, Soon Koo Baik, Seung Yong Shin, Jung Min Kim, Yong Seok Kang, Yoo Li Lim, Young Ju Kim, Youn Zoo Cho, Hye Won Hwang, Jin Hyung Lee, Myeong Hun Chae, Hyoun A Kim, Hye Won Kang, Sang Ok Kwon
    Clinical and Molecular Hepatology.2013; 19(4): 370.     CrossRef
  • Hemodynamic effects of continuous versus bolus infusion of terlipressin for portal hypertension: A randomized comparison
    Chao Ding, Xingjiang Wu, Xinxin Fan, Changsheng He, Jieshou Li
    Journal of Gastroenterology and Hepatology.2013; 28(7): 1242.     CrossRef
  • Hepatogenous Diabetes in Cirrhosis Is Related to Portal Pressure and Variceal Hemorrhage
    Hyo Keun Jeon, Moon Young Kim, Soon Koo Baik, Hong Jun Park, Hoon Choi, So Yeon Park, Bo Ra Kim, Jin Heon Hong, Ki Won Jo, Seung Yong Shin, Jung Min Kim, Jae Woo Kim, Hyun Soo Kim, Sang Ok Kwon, Young Ju Kim, Seung Hwan Cha, Dong Joon Kim, Ki Tae Suk, Gab
    Digestive Diseases and Sciences.2013; 58(11): 3335.     CrossRef
  • Influence of Nitric Oxide and cGMP on Agonist-Induced Platelet Adhesion – An In Vitro Study in Platelets Isolated from Patients with Liver Cirrhosis / Uticaj Azot-Oksida I cGMP Na Adheziju Trombocita Izazvanu Agonistima – In Vitro Studija Na Izolovanim Tr
    Sam Annie-Jeyachristy, Geetha Arumugam, Surendran Rajagopal, Jeevan Kumar Subburayan, Arulprakash Sarangapani
    Journal of Medical Biochemistry.2013; 32(1): 59.     CrossRef
  • Tissue mechanics and fibrosis
    Rebecca G. Wells
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2013; 1832(7): 884.     CrossRef
  • Intracerebroventricular losartan infusion modulates angiotensin II type 1 receptor expression in the subfornical organ and drinking behaviour in bile‐duct‐ligated rats
    Joseph D. Walch, Flávia Regina Carreño, J. Thomas Cunningham
    Experimental Physiology.2013; 98(4): 922.     CrossRef
  • The pathophysiology of hepatorenal syndrome
    Anna Gipson
    Gastrointestinal Nursing.2013; 11(7): 29.     CrossRef
  • Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis
    Moon Young Kim, Ki Tae Suk, Soon Koo Baik, Hyoun A. Kim, Young Ju Kim, Seung Hwan Cha, Hwa Ryun Kwak, Mee Yon Cho, Hong Jun Park, Hyo Keun Jeon, So Yeon Park, Bo Ra Kim, Jin Heon Hong, Ki Won Jo, Jae Woo Kim, Hyun Soo Kim, Sang Ok Kwon, Sei Jin Chang, Gwa
    Hepatology.2012; 56(3): 1053.     CrossRef
  • Comparison of Hepatic Venous Pressure Gradient and Two Models of End-stage Liver Disease for Predicting the Survival in Patients With Decompensated Liver Cirrhosis
    Ki Tae Suk, Chang Hoon Kim, Seung Ha Park, Ho Taik Sung, Jong Young Choi, Kwang Hyub Han, So Hyung Hong, Dae Yong Kim, Jai Hoon Yoon, Yeon Soo Kim, Gwang Ho Baik, Jin Bong Kim, Dong Joon Kim
    Journal of Clinical Gastroenterology.2012; 46(10): 880.     CrossRef
  • Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?
    Tae Wan Kim, Hong Joo Kim, Chang Uk Chon, Hyun Sun Won, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim
    Clinical and Molecular Hepatology.2012; 18(2): 203.     CrossRef
  • PPARα activation in portal hypertension
    Hongqun Liu, Samuel S. Lee, Roberto J. Groszmann, Yasuko Iwakiri, Tamar H. Taddei
    Hepatology.2012; 56(5): 1993.     CrossRef
  • 16,462 View
  • 188 Download
  • Crossref
Original Article
Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines
Sung Hoon Choi, Hye Won Shin, Jun Yong Park, Ji Young Yoo, Do Young Kim, Weon Sang Ro, Chae-Ok Yun, Kwang-Hyub Han
Korean J Hepatol 2010;16(3):280-287.
Published online September 30, 2010
DOI: https://doi.org/10.3350/kjhep.2010.16.3.280
Background/Aims

Hypoxia-inducible factor-1α (HIF-1α) is a central transcriptional factor involved in the cellular responses related to various aspects of cancer biology, including proliferation, survival, and angiogenesis, and the metabolism of the extracellular matrix in hypoxia. This study evaluated whether adenovirus-mediated small hairpin RNA (shRNA) against HIF-1α (shHIF-1α) inhibits cell proliferation and angiogenesis in hepatocellular carcinoma (HCC) cell lines.

Methods

Knockdown of HIF-1α expression was constructed by adenovirus-mediated RNA interference tools, and HCC cell lines infected with shHIF-1α coding virus were cultured under a hypoxia condition (1% O2) for 24 hours. Following infection, the expression levels of HIF-1α, angiogenesis factors, and matrix metalloproteinase (MMP) were examined using Western blotting. Cell proliferation and angiogenesis were measured by a cell proliferation assay (MTT assay) and an angiogenesis-related assay (invasion and tube-formation assay), respectively.

Results

Adenovirus mediated inhibition of HIF-1α induced suppression of tumor growth in HCC cell lines. It also down-regulated the expression of angiogenesis factor and MMP proteins. Angiogenesis as well as mobility of vascular cells to tumor was suppressed by adenovirus-mediated shHIF-1α-infected groups in human umbilical vein endothelial cells (HUVECs).

Conclusions

These data suggest that adenovirus-mediated inhibition of HIF-1α inhibits the invasion, tube formation, and cell growth in HUVECs and HCC cells.

Citations

Citations to this article as recorded by  Crossref logo
  • Therapeutic Synergy of Silibinin‐Loaded Nanogel and Low‐Dose Gamma Radiation in Hepatocellular Carcinoma: Emphasis on EMT, Angiogenesis, and Immune Response
    Zakaria Mohamed Alghzzawy, Mohammed Hussein Awwad, Tarek Khaled Elmaghraby, Sanaa Abd El‐Hamid Hagag, Azza Elsayed Kayed, Doaa Sabry Ibrahim
    Advanced Therapeutics.2025;[Epub]     CrossRef
  • RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity
    Sun-Mi Yoo, Cheol-Jung Lee, Hyun-Jung An, Joo Young Lee, Hye Suk Lee, Han Chang Kang, Sung-Jun Cho, Seung-Min Kim, Juhee Park, Dae Joon Kim, Yong-Yeon Cho
    International Journal of Molecular Sciences.2019; 20(8): 1994.     CrossRef
  • Stable knockdown of CREB, HIF-1 and HIF-2 by replication-competent retroviruses abrogates the responses to hypoxia in hepatocellular carcinoma
    D Shneor, R Folberg, J Pe'er, A Honigman, S Frenkel
    Cancer Gene Therapy.2017; 24(2): 64.     CrossRef
  • Tumor angiogenesis and vascular normalization: alternative therapeutic targets
    Claire Viallard, Bruno Larrivée
    Angiogenesis.2017; 20(4): 409.     CrossRef
  • ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α
    Joon Ho Lee, Wonhee Hur, Sung Woo Hong, Jung-Hee Kim, Sung Min Kim, Eun Byul Lee, Seung Kew Yoon
    Oncology Reports.2017; 37(2): 813.     CrossRef
  • RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells
    ChengShi Chen, Rong Liu, JianHua Wang, ZhiPing Yan, Sheng Qian, Wei Zhang
    Cell Biochemistry and Biophysics.2015; 71(3): 1677.     CrossRef
  • Inhibition of tumour angiogenesis and growth by small hairpin HIF‐1α and IL‐8 in hepatocellular carcinoma
    Sung Hoon Choi, Oh‐Joon Kwon, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Simon Weonsang Ro, Kyung Sik Kim, Jeon Han Park, Seungtaek Kim, Chae‐Ok Yun, Kwang‐Hyub Han
    Liver International.2014; 34(4): 632.     CrossRef
  • The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma
    Dongjun Luo, Zhongxia Wang, Junyi Wu, Chunping Jiang, Junhua Wu
    BioMed Research International.2014; 2014: 1.     CrossRef
  • Expression and significance of MMP2 and HIF-1α in hepatocellular carcinoma
    BIN WANG, YOU-MING DING, PING FAN, BING WANG, JUN-HUI XU, WEI-XING WANG
    Oncology Letters.2014; 8(2): 539.     CrossRef
  • Signaling pathways bridging microbial-triggered inflammation and cancer
    Maulilio John Kipanyula, Paul Faustin Seke Etet, Lorella Vecchio, Mohammed Farahna, Elias Nchiwan Nukenine, Armel Hervé Nwabo Kamdje
    Cellular Signalling.2013; 25(2): 403.     CrossRef
  • The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma
    Shi-Yun Cui, Jia-Yuan Huang, Yi-Tian Chen, Hai-Zhu Song, Gui-Chun Huang, Wei De, Rui Wang, Long-Bang Chen
    Cell Cycle.2013; 12(17): 2849.     CrossRef
  • Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis
    Jin-Wook Kim
    The Korean Journal of Hepatology.2010; 16(3): 278.     CrossRef
  • 11,905 View
  • 68 Download
  • Crossref